Citations (21)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Michael H. Andreae, Evelyn Rhodes, Tyler Bourgoise, George M. Carter, Robert S. White, Debbie Indyk, Henry Sacks & Rosamond Rhodes. (2016) An Ethical Exploration of Barriers to Research on Controlled Drugs. The American Journal of Bioethics 16:4, pages 36-47.
Read now
Read now
A. Fogarty, P. Rawstorne, G. Prestage, J. Crawford, J. Grierson & S. Kippax. (2007) Marijuana as therapy for people living with HIV/AIDS: Social and health aspects. AIDS Care 19:2, pages 295-301.
Read now
Read now
Stephen Sidney. (2001) Marijuana Use in HIV-Positive and AIDS Patients. Journal of Cannabis Therapeutics 1:3-4, pages 35-41.
Read now
Read now
ClintonA. Werner. (2001) Medical Marijuana and the AIDS Crisis. Journal of Cannabis Therapeutics 1:3-4, pages 17-33.
Read now
Read now
Articles from other publishers (17)
Mason Clay Mathews & A. Stewart Fotheringham. (2024) The effect of place on voting behavior: The case of the Arizona proposition to legalize recreational marijuana. Politics & Policy 52:1, pages 196-226.
Crossref
Crossref
Estefanía Moreno, Milena Cavic, Ana Krivokuca, Vicent Casadó & Enric Canela. (2019) The Endocannabinoid System as a Target in Cancer Diseases: Are We There Yet?. Frontiers in Pharmacology 10.
Crossref
Crossref
Qiang Wei, Li Liu, Zhe Cong, Xiaoxian Wu, Hui Wang, Chuan Qin, Patricia Molina & Zhiwei Chen. (2016) Chronic Δ9-Tetrahydrocannabinol Administration Reduces IgE+B Cells but Unlikely Enhances Pathogenic SIVmac251 Infection in Male Rhesus Macaques of Chinese Origin. Journal of Neuroimmune Pharmacology 11:3, pages 584-591.
Crossref
Crossref
Michael H. Andreae, George M. Carter, Naum Shaparin, Kathryn Suslov, Ronald J. Ellis, Mark A. Ware, Donald I. Abrams, Hannah Prasad, Barth Wilsey, Debbie Indyk, Matthew Johnson & Henry S. Sacks. (2015) Inhaled Cannabis for Chronic Neuropathic Pain: A Meta-analysis of Individual Patient Data. The Journal of Pain 16:12, pages 1221-1232.
Crossref
Crossref
Akan Das, Sumi Chaudhury, Mohan C. Kalita & Tapan K. Mondal. (2015) In silico identification, characterization and expression analysis of miRNAs in Cannabis sativa L.. Plant Gene 2, pages 17-24.
Crossref
Crossref
Benedikt Fischer, Yoko Murphy, Paul Kurdyak, Elliot Goldner & Jürgen Rehm. (2015) Medical marijuana programs — Why might they matter for public health and why should we better understand their impacts?. Preventive Medicine Reports 2, pages 53-56.
Crossref
Crossref
Ethan B Russo. 2012. Cannabis Therapeutics in HIV/AIDS. Cannabis Therapeutics in HIV/AIDS
41
47
.
G. Benze, A. Geyer, B. Alt-Epping & F. Nauck. (2013) Behandlung von Übelkeit und Erbrechen mit 5HT3-Antagonisten, Steroiden, Antihistaminika, Anticholinergika, Somatostatinanaloga, Benzodiazepinen und Cannabinoiden bei PalliativpatientenTreatment of nausea and vomiting with 5HT3 receptor antagonists, steroids, antihistamines, anticholinergics, somatostatinantagonists, benzodiazepines and cannabinoids in palliative care patients. Der Schmerz 26:5, pages 481-499.
Crossref
Crossref
Gillinder Bedi, Richard W. Foltin, Erik W. Gunderson, Judith Rabkin, Carl L. Hart, Sandra D. Comer, Suzanne K. Vosburg & Margaret Haney. (2010) Efficacy and tolerability of high-dose dronabinol maintenance in HIV-positive marijuana smokers: a controlled laboratory study. Psychopharmacology 212:4, pages 675-686.
Crossref
Crossref
Amanda Reiman. (2016) Medical Cannabis Patients: Patient Profiles and Health Care Utilization Patterns. Complementary health practice review 12:1, pages 31-50.
Crossref
Crossref
Wen-Hung KuoTracey E. WilsonKathleen M. WeberValsa MadhavaJean RichardsonRobert DelapenhaDon Des Jarlais. (2004) Initiation of Regular Marijuana Use Among a Cohort of Women Infected with or at Risk for HIV in the Women's Interagency HIV Study (WIHS). AIDS Patient Care and STDs 18:12, pages 702-713.
Crossref
Crossref
Diane Prentiss, Rachel Power, Gladys Balmas, Gloria Tzuang & Dennis M. Israelski. (2004) Patterns of Marijuana Use Among Patients With HIV/AIDS Followed in a Public Health Care Setting. JAIDS Journal of Acquired Immune Deficiency Syndromes 35:1, pages 38-45.
Crossref
Crossref
Barry M. Bredt, Dana Higuera‐Alhino, Starley B. Shade, Samuel J. Hebert, Joseph M. McCune & Donald I. Abrams. (2014) Short‐Term Effects of Cannabinoids on Immune Phenotype and Function in HIV‐1‐Infected Patients. The Journal of Clinical Pharmacology 42:S1.
Crossref
Crossref
James E. Koch. (2001) Δ9-THC stimulates food intake in Lewis rats: effects on chow, high-fat and sweet high-fat diets. Pharmacology Biochemistry and Behavior 68:3, pages 539-543.
Crossref
Crossref
Donald I. Abrams. (2000) Potential Interventions for HIV/AIDS Wasting: An Overview. JAIDS Journal of Acquired Immune Deficiency Syndromes 25, pages S74-S80.
Crossref
Crossref
Donald I. Abrams. (2000) Potential Interventions for HIV/AIDS Wasting: An Overview. Journal of Acquired Immune Deficiency Syndromes, pages S74-S80.
Crossref
Crossref
Emil Pop. (1999) Cannabinoids, endogenous ligands and synthetic analogs. Current Opinion in Chemical Biology 3:4, pages 418-425.
Crossref
Crossref